CD44 and cancer: Immunohistochemical analysis of tumor tissues injected with 2B7 revealed decreased expression of the cancer stem cell (CSC) marker CD44, as well as changes in the epithelial-mesenchymal transition (EMT) markers E-cadherin and vimentin (Figure 2C).